Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial

Abstract

Journal of Hematology & Oncology (2025) 18:56

https://doi.org/10.1186/s13045-025-01713-2

The original article has been corrected to restore co-authors Yi Su, Ling Qiu, and Fang-yi Fan (lead contact) to co-Corresponding Authorship which was mistakenly removed by the production team which handled this article.

Author notes

1. Hao Yao, Shi-hui Ren, Lin-hui Wang and Ming-qiang Ren contributed equally to this work.

Authors and Affiliations

1. Department of Hematology, Chinese People’s Liberation Army The General Hospital of Western Theater Command, Chengdu, 610083, Sichuan, China

   Hao Yao, Shi-hui Ren, Jiao Cai, Dan Chen, Ying He, Si-han Lai, Bai-tao Dou, Meng-jiao Li, Yan-ling Li, Ya-li Cen, Yi Su, Ling Qiu & Fang-yi Fan

2. Branch of National Clinical Research Center for Hematological Disease, Chengdu, 610083, Sichuan, China

   Hao Yao, Shi-hui Ren, Jiao Cai, Dan Chen, Ying He, Si-han Lai, Bai-tao Dou, Meng-jiao Li, Yan-ling Li, Ya-li Cen, Yi Su, Ling Qiu & Fang-yi Fan

3. Sichuan Clinical Research Center for Hematological Disease, Chengdu, 610083, China

   Hao Yao, Shi-hui Ren, Jiao Cai, Dan Chen, Ying He, Si-han Lai, Bai-tao Dou, Meng-jiao Li, Yan-ling Li, Ya-li Cen, Yi Su, Ling Qiu & Fang-yi Fan

4. Department of Clinical Medicine, North Sichuan Medical College, Nanchong, 637000, Sichuan, China

   Bai-tao Dou, Meng-jiao Li, Yan-ling Li & Fang-yi Fan

5. Institute of Basic Medicine, North Sichuan Medical College, Nanchong, 637000, Sichuan, China

   Hao Yao

6. Department of Hematology, The People’s Hospital of Guizhou Province, Guiyang, 550002, Guizhou, China

   Lin-hui Wang

7. Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou Province, China

   Ming-qiang Ren

8. Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, 200438, China

   Alex H. Chang

9. Shanghai YaKe Biotechnology Ltd., Yangpu District, Shanghai, 200090, China

   Alex H. Chang

Authors

1. Hao YaoView author publications

   You can also search for this author inPubMed Google Scholar

2. Shi-hui RenView author publications

   You can also search for this author inPubMed Google Scholar

3. Lin-hui WangView author publications

   You can also search for this author inPubMed Google Scholar

4. Ming-qiang RenView author publications

   You can also search for this author inPubMed Google Scholar

5. Jiao CaiView author publications

   You can also search for this author inPubMed Google Scholar

6. Dan ChenView author publications

   You can also search for this author inPubMed Google Scholar

7. Ying HeView author publications

   You can also search for this author inPubMed Google Scholar

8. Si-han LaiView author publications

   You can also search for this author inPubMed Google Scholar

9. Bai-tao DouView author publications

   You can also search for this author inPubMed Google Scholar

10. Meng-jiao LiView author publications

    You can also search for this author inPubMed Google Scholar

11. Yan-ling LiView author publications

    You can also search for this author inPubMed Google Scholar

12. Ya-li CenView author publications

    You can also search for this author inPubMed Google Scholar

13. Alex H. ChangView author publications

    You can also search for this author inPubMed Google Scholar

14. Yi SuView author publications

    You can also search for this author inPubMed Google Scholar

15. Ling QiuView author publications

    You can also search for this author inPubMed Google Scholar

16. Fang-yi FanView author publications

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence to Hao Yao, Yi Su, Ling Qiu or Fang-yi Fan.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Cite this article

Yao, H., Ren, Sh., Wang, Lh. et al. Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial. J Hematol Oncol 18, 60 (2025). https://doi.org/10.1186/s13045-025-01714-1

Download citation

• Published: 03 June 2025

• DOI: https://doi.org/10.1186/s13045-025-01714-1

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative